The 9p21 region in bladder cancer cell lines: Large homozygous deletions inactivate the CDKN2, CDKN2B and MTAP genes

Urological Research

Volumn 24, Issue 4, 1996, Pages 239-244

  Stadler, W M ^a   Olopade, O I ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Cell cycle inhibitors; INK4; INK4b; MTS; MTS2; p15; p16

Indexed keywords

ARTICLE; BLADDER CANCER; CELL CYCLE; CELL LINE; CHROMOSOME 9P; GENE DELETION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0029791633     PISSN: 03005623     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00295899     Document Type: Article

References (31)

1. Cairns P, Tokino K, Eby Y, Sidranksy D (1994a) Homozygous deletion of 9p21 in primary human bladder tumors detected by competitive multiplex polymerase chain reaction. Cancer Res 54:1422
2. Cairns P, Mao L, Merlo A, Lee DJ, Eby Y, Tokino K, Riet P, Blaugrund JE, Sidransky D (1994b) Rates of p16 (MTS1) mutations in primary tumors with 9p loss. Science (Washington DC) 265:415
3. Cairns P, Polascik TJ, Eby Y, Tokino K, Colifano J et al (1995) Frequency of homozygous deletions at p16, CDKN2 in primary human tumors. Nature Gen 11:210
4. Cheng JQ, Jhanwar SC, Lu YY, Testa JR (1993) Homozygous deletions within 9p21-22 identify a small critical region of chromosomal loss in human malignant mesotheliomas. Cancer Res 53:4761
5. Dreyling MH, Bohlander SK, Adeyanju MO, Olopade OI (1995) Detection of CDKN2 deletions in tumor cell lines and primary glioma by interphase fluorescence in situ hybridization. Cancer Res 55:984
6. Fountain JW, Karayiorgou M, Ernstoff MS et al (1992) Homozygous deletions within human chromosome band 9p21 in melanoma. Proc Natl Acad Sci USA 89:10557
7. INK4 locus in squamous cell carcinoma distinguish it from transitional cell carcinoma of the bladder. J Natl Cancer Inst 87:1383
8. Goodrich DW, Chen Y, Scully P, Lee W-H (1992) Expression of the retinoblastoma gene product in bladder carcinoma cells associates with a low frequency of tumor formation. Cancer Res 52:1968
9. INK4b is a potential effector of TGF-β-induced cell cycle arrest. Nature 371:257
10. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigain SV, Stockert E, Day RS, Johnson BE, Skolnick MH (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science (Washington DC) 264:436
11. Knudson AG (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68:1631
12. Kwiatkowski K, Diaz M (1992) A dinucleotide repeat in the human IFNA Locus. Human Mol Gen 1:658
13. Liu Q, Neuhausen S, McClure M, Frye C, Weaver-Feldhaus J, Gruis NA, Eddington K, Allalunis-Turner MJ, Skolnick MH, Fujimara FK, Kamb A (1995) CDKN2 (MTS1) tumor suppressor gene mutations in human tumor cell lines. Oncogene 10:1061
14. INK4A transcript. Cancer Res 55:2995
15. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB, Siransky D (1995) 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nature Med 1:686
16. Miyao N, Tsai YL, Lerner SP, et al (1993) Role of chromosome 9 in human bladder cancer. Cancer Res 53:4066
17. Mosman T (1983) Rapid colorimetric assay for cellular growth and survival. Application to proliferation and cytotoxicity asssays. J Immunol Meth 65:55
18. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA (1994) Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature (London) 368:753
19. Olopade OI, Buchhagen DL, Malik K et al (1993) Homozygous loss of the interferon genes defines the critical region on 9p that is deleted in lung cancers. Cancer Res 53:2410
20. Olopade OI, Pomykala HM, Hagos F, Sveen LW, Espinosa R III, Dreyling MH, Gursky S, Stadler WM, LeBeau MM, Bohlander SK (1995) Construction of a 2.8 mega base YAC contig and cloning of the methylthioadenosine phosphorylase (MTAP) gene from the tumor suppressor locus on 9p21. Proc Natl Acad Sci USA 92:6489
21. Perucca D, Szepetowske P, Simon M-P, Gaudray P (1990) Molecular genetics of human bladder carcinomas. Cancer Genet Cytogenet 49:143
22. Porterfield BW, Pomykala H, Maltepe E, Bohlander SK, Rowley JD, Diaz MO (1993) The use of methylthioadenosine phosphorylase activity to select for human chromosome 9 in interspecies and intraspecies hybrid cells. Som Cell Mol Gen 19:469
23. Ruppert JM, Tokino K, Sidransky D (1993) Evidence for two bladder cancer suppressor loci on human chromosome 9. Cancer Res 53:5093
24. Serrano M, Hannon GJ, Beach D (1993) A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D CDK4. Nature 366:704
25. Spruck CH III, Gonzalez-Zulueta M, Shibata A, Simoneau AR, Lin MF, Gonzales F, Tsai YC, Jones PA (1994) p16 gene in uncultured tumors. Nature (London) 370:183
26. Stadler WM, Sherman J, Bohlander SK, Roulston D, Dreyling M, Rukstalis D, Olopade OI (1994) Homozygous deletions within chromosomal bands 9p21-22 in bladder cancer. Cancer Res 54:2060
27. Tarmin L, Yin J, Zhou X, Suzuki H, Jiang H-Y et al (1994) Frequent loss of heterozygosity on chromosome 9 in adenocarcinoma and squamous cell carcinoma of the oesophagus. Cancer Res 54:6094
28. Van der Riet P, Nawroz H, Hruban RH, Corio R, Tokino K, Koch W, Sidransky D (1994) Frequent loss of chromosome 9p21-22 early in head and neck cancer progression. Cancer Res 54:1156
29. Weissenbach J, Gyapay G, Dib C, Vignal A, Morissette J, Millasseau P, Vaysseix G, Lathrop M (1992) A second-generation linkage map of the human genome. Nature (London) 359:794
30. Yeager T, Stadler W, Belair C, Puthenveettil J, Olopade O, Reznikoff C (1995) Increased p16 levels correlate with pRb alterations in human urothelial cells. Cancer Res 55:493
31. INK4) in human breast carcinomas. Cancer Res 54:5262